Home › Gastrointestinal Stromal Tumors › Missouri › St. Louis
Gastrointestinal Stromal Tumors clinical trials in St. Louis, MO
3 studies for Gastrointestinal Stromal Tumors are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
- GSK Investigational Site, St Louis
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
RecruitingPhase 1/2
- Washington University School of Medicine - Siteman Cancer Center, St Louis
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
RecruitingPhase 3
- Washington University, St Louis
Gastrointestinal Stromal Tumors trials in other cities
- Miami, FL8 studies
- Boston, MA7 studies
- New York City, NY7 studies
- Houston, TX6 studies
- Philadelphia, PA6 studies
- Nashville, TN5 studies
- San Diego, CA5 studies
- Portland, OR5 studies
- Omaha, NE5 studies
- Dallas, TX4 studies
- Durham, NC4 studies
- Ann Arbor, MI4 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Cancer (all types)46 studies
- Prostate Cancer46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.